Skip to main content
Clinical Trials/NCT00872937
NCT00872937
Unknown
Not Applicable

Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions

National Taiwan University Hospital1 site in 1 country800 target enrollmentMarch 2009
ConditionsCervical Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
National Taiwan University Hospital
Enrollment
800
Locations
1
Primary Endpoint
overall survival
Last Updated
13 years ago

Overview

Brief Summary

Human papillomavirus (HPV) infection plays a key role in the carcinogenesis of cervical cancer and pre-invasive lesions. There are hundred types of HPV, including high risk and low risk types, and it is proved the close association between the cervical cancer and high risk HPV. While HPV 16 and 18 are known to be the leading two genotypes detected in women with cervical neoplasm worldwide, there is considerable difference in the other prevalent high risk genotypes in different geographic areas. It is important to establish the local database about the cervical intraepithelial lesions and the related prevalent HPV genotypes. The investigators designed a retrospective study which included total 784 patients managed at our hospital from January 1, 2000 to December 31, 2007. The present study was to investigate the HPV genotypes in the Taiwanese female patients with abnormal cervical cytology and analyses the association between HPV types and cervical pre-invasive lesions. It could provide the guide for the clinicians in the management of patients with abnormal cytological change of Pap smear.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
December 2012
Last Updated
13 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers
  • People infected with HPV type 16 but without CIN lesions
  • Patients with CIN lesions
  • Patients with cervical cancer from National Taiwan University Hospital
  • Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

overall survival

Time Frame: from disease diagnosis to death

Study Sites (1)

Loading locations...

Similar Trials